7 mins read

Drug Pricing Reform Without Price Controls: Why Innovation Matters More Than Imported Policies

The debate over drug pricing in the United States has intensified in recent years, with policymakers searching for solutions to rising healthcare costs. One proposal gaining traction is the adoption of “most favored nation” (MFN) pricing—a system that ties U.S. drug prices to the lowest prices paid in other countries. While the idea may appear […]

7 mins read

Healthcare Reform Debate: How Republicans Could Turn a Policy Challenge Into a Strategic Victory

As Congress revisits the future of enhanced Affordable Care Act (ACA) subsidies, the healthcare debate in the United States has once again reached a critical crossroads. Lawmakers must decide whether to extend temporary measures introduced during the COVID-19 pandemic or pivot toward long-term reforms aimed at improving affordability, expanding access, and empowering patients. This decision […]